NGT BioPharma Consultants understand the challenges companies face when preparing drug candidates for the clinic and the continuing need for nonclinical study support throughout the development process. To foster development success, we work collaboratively with our clients to efficiently navigate the many interdependent processes, expediting progression into the clinic and beyond.
We leverage our collective expertise and extensive experience to (i) Generate fit-for-purpose product development plans; (ii) Evaluate risk, intellectual property, and market/competitor intelligence; (iii) Provide evidence for safety while linking preclinical data to human disease; (iv) Outsource and manage nonclinical study activities; and (v) Liaise with US, European and other international regulatory agencies. We provide preclinical consultancy in close alignment with NGT consultants experienced in Clinical, CMC, Regulatory, and Quality/Compliance disciplines to offer services that include, but are not limited to, the following:
Although NGT is neither a laboratory or manufacturing services provider, we can serve as your single point of contact to our network of reputable CRO’s and CDMO ’s.